Sign in
BCTXL Stock Price, Chart, Stats & News
BriaCell Therapeutics Corp.
Save
BriaCell Therapeutics Corp. (BCTXL) does not currently pay a dividend.
9.13M
Market cap
–
Current P/E
–
Forward P/E
BCTXL chart
About
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L.
Similar securities
Based on sector and market capitalization
Report issue